↑Weston, K. (2011). «Translating metabolic biochemistry into the clinic: An interview with Steve O'Rahilly». Disease Models & Mechanisms. 4 (2): 141–144. doi:10.1242/dmm.007641
↑Oʼrahilly, Stephen; Montague, C. T.; Farooqi, I. S.; Whitehead, J. P.; Soos, M. A.; Rau, H.; Wareham, N. J.; Sewter, C. P.; Digby, J. E.; Mohammed, S. N.; Hurst, J. A.; Cheetham, C. H.; Earley, A. R.; Barnett, A. H.; Prins, J. B. (1997). «Congenital leptin deficiency is associated with severe early-onset obesity in humans». Nature. 387 (6636): 903–8. PMID9202122. doi:10.1038/43185
↑Seminara, S. B.; Messager, S.; Chatzidaki, E. E.; Thresher, R. R.; Acierno, J. S.; Shagoury, J. K.; Bo-Abbas, Y.; Kuohung, W.; Schwinof, K. M.; Hendrick, A. G.; Zahn, D.; Dixon, J.; Kaiser, U. B.; Slaugenhaupt, S. A.; Gusella, J. F.; O'Rahilly, S.; Carlton, M. B. L.; Crowley, W. F.; Aparicio, S. A. J. R.; Colledge, W. H. (2003). «TheGPR54Gene as a Regulator of Puberty». New England Journal of Medicine. 349 (17): 1614–27. PMID14573733. doi:10.1056/NEJMoa035322
↑Farooqi, I. S.; Jebb, S. A.; Langmack, G.; Lawrence, E.; Cheetham, C. H.; Prentice, A. M.; Hughes, I. A.; McCamish, M. A.; O'Rahilly, S. (1999). «Effects of Recombinant Leptin Therapy in a Child with Congenital Leptin Deficiency». New England Journal of Medicine. 341 (12): 879–84. PMID10486419. doi:10.1056/NEJM199909163411204
↑Payne, F.; Lim, K.; Girousse, A.; Brown, R. J.; Kory, N.; Robbins, A.; Xue, Y.; Sleigh, A.; Cochran, E.; Adams, C.; Dev Borman, A.; Russel-Jones, D.; Gorden, P.; Semple, R. K.; Saudek, V.; O'Rahilly, S.; Walther, T. C.; Barroso, I.; Savage, D. B. (2014). «Mutations disrupting the Kennedy phosphatidylcholine pathway in humans with congenital lipodystrophy and fatty liver disease». Proceedings of the National Academy of Sciences. 111 (24): 8901–8906. doi:10.1073/pnas.1408523111